Results 231 to 240 of about 37,731,658 (401)
Molecular Oncology, EarlyView.Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva +5 more
wiley +1 more source
Incidental detection of rare metastatic basal cell carcinoma on screening mammography. [PDF]
Radiol Case RepDiTommaso A +3 more
europepmc +1 more source
A Histologic and Electron Microscopic Study of a Pigmenting Basal Cell Epithelioma*
, 1961 Alvin S. Zelickson +2 more
openalex +1 more source
Molecular Oncology, EarlyView.Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon +13 more
wiley +1 more source
Current diagnosis and treatment of basal cell carcinoma
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2015 M. Alter +4 more
semanticscholar +1 more source
Basal Cell Nevus Syndrome and Sporadic Basal Cell Carcinoma: A Comparative Study of Clinicopathological Features. [PDF]
Acta Derm VenereolWang CY +12 more
europepmc +1 more source
Basal cell adenoma of the parotid gland. Case report with ultrastructural observations [PDF]
, 1976 Mario A. Luna, Bruce Mackay
openalex +1 more source
Molecular Oncology, EarlyView.In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková +14 more
wiley +1 more source